[Form 4] CeriBell, Inc. Insider Trading Activity
Ceribell, Inc. insider Raymond Woo, the company's Chief Technology Officer, exercised options under a Rule 10b5-1 plan on 09/02/2025. He acquired 20,000 shares of Common Stock by exercising stock options at a $2.24 exercise price. Following the transaction, the reporting person beneficially owns 167,704 shares of common stock and directly holds 20,000 underlying shares from the exercised option. The option granted is fully vested and exercisable and has an expiration date of 06/10/2029. The Form 4 was signed by an attorney-in-fact on 09/04/2025.
- Transaction executed under a Rule 10b5-1 trading plan, which documents prearranged trading and reduces concerns about opportunistic timing
- Insider exercised fully vested options, indicating access to previously granted compensation rather than a new grant
- Form 4 filed promptly (transaction dated 09/02/2025, Form signed 09/04/2025), showing timely disclosure
- None.
Insights
TL;DR: Insider exercised options for 20,000 shares at $2.24 under a 10b5-1 plan, increasing direct holdings to 167,704 shares.
The exercise indicates non-discretionary execution under a pre-established Rule 10b5-1 trading plan, which typically reduces timing risk and signaling concerns about opportunistic insider trades. The transaction involved 20,000 option shares exercised at $2.24, with the options fully vested and exercisable and expiring 06/10/2029. For investors, this is a routine insider liquidity event rather than an operational disclosure; it slightly increases the insider's direct share count but does not provide new financial results or prospects.
TL;DR: The trade followed a 10b5-1 plan and was reported promptly, consistent with standard insider reporting practices.
The filing explicitly states the exercise was effected pursuant to a Rule 10b5-1 trading plan and the Form 4 was filed with a dated signature on 09/04/2025. The reporting person is the CTO and the filing identifies direct ownership amounts after the transaction. From a governance perspective, documentation of the 10b5-1 plan and timely Form 4 disclosure align with compliance expectations for insider transactions.